Menu

California Institutes to Merge

The Scripps Research Institute will join forces with the California Institute for Biomedical Research.

Oct 25, 2016
Jef Akst

FLICKR, HÅKAN DAHLSTRÖMChemist Peter Schultz is bringing together his two nonprofit institutions—the Scripps Research Institute (TSRI) and the California Institute for Biomedical Research (Calibr)—merging them into a new biomedical research entity, according to a statement issued last week (October 20). The hope is that basic research conducted at TSRI can be fed into Calibr for preclinical and clinical development.

“The affiliation between TSRI and Calibr is the first of its kind,” Schultz, who is president of both organizations, said in the press release. “Unlike other research institutes and universities that have sought to establish translational capabilities within academic centers, we aren’t building from scratch—rather, we are integrating the strengths of two proven nonprofit organizations.”

The two institutions have collaborated since Calibr was launched in 2012, but the merge will allow them to share a board of directors as well as scientific and administrative resources, reducing overhead costs for both organizations. 

(Hat tip: Science)

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.